Valuation: CARMAT

Market Cap 6.15M 7.03M 5.65M 5.26M 9.98M 669M 10.13M 67.74M 26.36M 329M 26.37M 25.81M 1.13B P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 59.25M 67.75M 54.46M 50.75M 96.23M 6.45B 97.65M 653M 254M 3.17B 254M 249M 10.94B EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 55 2016-08-31
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2025-03-31
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 2017-01-01
Director/Board Member 79 2017-04-19
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%-.--% - - 7.08M
+4.20%-1.85%-17.39%+9.58% 125B
+0.04%-1.01%+1.39%-6.08% 12.77B
+7.83%+2.71%+43.32%+112.86% 8.71B
+2.29%+7.17%-46.92%-72.29% 4.07B
+4.16%+8.39%+25.37%+43.89% 2.73B
+2.53%+23.07%-7.66%-13.04% 1.89B
+3.55%+8.85%-0.99%-23.29% 1.67B
-5.25%-5.89%+179.33%+133.76% 1.46B
Average +2.09%+1.23%+22.06%+23.17% 19.81B
Weighted average by Cap. +3.90%+2.90%-10.46%+13.01%

Financials

2023 2024
Net sales 3.84M 4.39M 3.53M 3.29M 6.23M 418M 6.32M 42.29M 16.45M 205M 16.47M 16.11M 709M 7.34M 8.4M 6.75M 6.29M 11.93M 800M 12.11M 80.95M 31.49M 393M 31.52M 30.84M 1.36B
Net income -53.87M -61.6M -49.52M -46.15M -87.5M -5.87B -88.79M -594M -231M -2.88B -231M -226M -9.95B -51.4M -58.77M -47.24M -44.03M -83.48M -5.6B -84.71M -566M -220M -2.75B -221M -216M -9.49B
Net Debt 49.64M 56.76M 45.63M 42.52M 80.62M 5.41B 81.81M 547M 213M 2.66B 213M 208M 9.17B 53.1M 60.72M 48.81M 45.49M 86.25M 5.78B 87.52M 585M 228M 2.84B 228M 223M 9.81B
Logo CARMAT
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
-